Dr. Scott Haldeman

MD | Neurology


  801 N Tustin Ave, Suite 202, Santa Ana
     California, 92705-3612
  714-547-9822    714-547-0443 Maps & Directions
Dr. Scott Haldeman is a Santa Ana, California based neurologist who is specialized in Neurology. His current practice location is 801 N Tustin Ave, Suite 202, Santa Ana. Patients can reach him at 714-547-9822 or can fax him at 714-547-0443. Dr. Scott Haldeman is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1821193509.
Dr. Scott Haldeman specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Scott Haldeman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Scott Haldeman
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:801 N Tustin Ave, Suite 202, Santa Ana,
California, 92705-3612
Phone:714-547-9822
Fax:714-547-0443
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1821193509
NPI Enumeration Date: 14 Sep, 2006
NPI Last Update On: 12 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Scott Haldeman
10131 Brier Lane,
Santa Ana, California
Zip: 92705
Phone Number: 714-838-9975
Fax Number: 714-838-5947
Patients can reach Dr. Scott Haldeman at 801 N Tustin Ave, Suite 202, Santa Ana, California or can call to book an appointment on 714-547-9822.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.